Avid Bioservices Inc (CDMO)
10.50
+0.23
(+2.24%)
USD |
NASDAQ |
Nov 04, 13:15
Avid Bioservices Total Assets (Quarterly): 334.64M for July 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 334.64M |
| April 30, 2024 | 336.56M |
| January 31, 2024 | 455.23M |
| October 31, 2023 | 454.64M |
| July 31, 2023 | 442.34M |
| April 30, 2023 | 451.57M |
| January 31, 2023 | 450.43M |
| October 31, 2022 | 441.85M |
| July 31, 2022 | 451.22M |
| April 30, 2022 | 429.84M |
| January 31, 2022 | 314.10M |
| October 31, 2021 | 301.63M |
| July 31, 2021 | 270.53M |
| April 30, 2021 | 265.51M |
| January 31, 2021 | 168.18M |
| October 31, 2020 | 113.60M |
| July 31, 2020 | 105.56M |
| April 30, 2020 | 107.62M |
| January 31, 2020 | 105.22M |
| October 31, 2019 | 105.25M |
| July 31, 2019 | 102.07M |
| April 30, 2019 | 78.40M |
| January 31, 2019 | 76.11M |
| October 31, 2018 | 80.22M |
| July 31, 2018 | 84.71M |
| Date | Value |
|---|---|
| April 30, 2018 | 95.76M |
| January 31, 2018 | 69.86M |
| October 31, 2017 | 78.63M |
| July 31, 2017 | 100.28M |
| April 30, 2017 | 118.11M |
| January 31, 2017 | 111.32M |
| October 31, 2016 | 109.94M |
| July 31, 2016 | 105.60M |
| April 30, 2016 | 109.04M |
| January 31, 2016 | 119.05M |
| October 31, 2015 | 112.66M |
| July 31, 2015 | 92.03M |
| April 30, 2015 | 97.46M |
| January 31, 2015 | 79.12M |
| October 31, 2014 | 81.44M |
| July 31, 2014 | 87.61M |
| April 30, 2014 | 90.54M |
| January 31, 2014 | 76.48M |
| October 31, 2013 | 55.11M |
| July 31, 2013 | 53.32M |
| April 30, 2013 | 45.06M |
| January 31, 2013 | 37.16M |
| October 31, 2012 | 36.53M |
| July 31, 2012 | 31.51M |
| April 30, 2012 | 28.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
105.22M
Minimum
Jan 2020
455.23M
Maximum
Jan 2024
315.80M
Average
334.64M
Median
Jul 2024
Total Assets (Quarterly) Benchmarks
| MEI Pharma Inc | 41.38M |
| Altimmune Inc | 173.35M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 276.01M |
| Shareholders Equity (Quarterly) | 58.64M |
| Debt to Equity Ratio | 2.624 |
| Current Ratio | 1.458 |
| Net Debt Paydown Yield | -0.40% |